Published in JAMA on January 13, 2010
Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci (2011) 2.60
Genome-environment interactions that modulate aging: powerful targets for drug discovery. Pharmacol Rev (2011) 1.42
Genetic studies reveal the role of the endocrine and metabolic systems in aging. J Clin Endocrinol Metab (2010) 1.13
Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships? Biochim Biophys Acta (2010) 1.11
Whole-Genome Sequencing of a Healthy Aging Cohort. Cell (2016) 1.03
Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol (2011) 0.98
Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline. J Am Geriatr Soc (2010) 0.96
The place of genetics in ageing research. Nat Rev Genet (2012) 0.95
Non-native language use and risk of incident dementia in the elderly. J Alzheimers Dis (2012) 0.95
Lipid lowering agents, cognitive decline, and dementia: the three-city study. J Alzheimers Dis (2012) 0.95
Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica. J Alzheimers Dis (2011) 0.91
Role of APOE genotype in gait decline and disability in aging. J Gerontol A Biol Sci Med Sci (2013) 0.86
Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis (2013) 0.85
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell (2011) 0.83
Trans-ethnical shift of the risk genotype in the CETP I405V with longevity: a Chinese case-control study and meta-analysis. PLoS One (2013) 0.83
CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging Behav (2012) 0.83
Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids Health Dis (2012) 0.83
Discovery of novel non-synonymous SNP variants in 988 candidate genes from 6 centenarians by target capture and next-generation sequencing. Mech Ageing Dev (2013) 0.82
An assessment of CETP sequence variation in relation to cognitive decline and dementia risk. Int J Mol Epidemiol Genet (2011) 0.82
Aging and neurogenesis, a lesion from Alzheimer's disease. Aging Dis (2010) 0.82
Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. Curr Vasc Pharmacol (2014) 0.82
Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol. Front Genet (2014) 0.81
Reduced prevalence of cognitive impairment in families with exceptional longevity. JAMA Neurol (2013) 0.81
Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics. Int J Alzheimers Dis (2012) 0.81
Parental longevity is associated with cognition and brain ageing in middle-aged offspring. Age Ageing (2013) 0.80
Integration of immunity with physical and cognitive function in definitions of successful aging. Aging Dis (2012) 0.80
We are ageing. Biomed Res Int (2014) 0.79
Personality, self-rated health, and cognition in centenarians: do personality and self-rated health relate to cognitive function in advanced age? Aging (Albany NY) (2013) 0.79
Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span. Cold Spring Harb Perspect Med (2015) 0.79
Circulating biomarkers that predict incident dementia. Alzheimers Res Ther (2014) 0.77
Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism. J Neural Transm (Vienna) (2015) 0.76
Population-based analysis of cholesteryl ester transfer protein identifies association between I405V and cognitive decline: the Cache County Study. Neurobiol Aging (2014) 0.75
Correcting Bias Caused by Missing Data in the Estimate of the Effect of Apolipoprotein ε4 on Cognitive Decline. J Int Neuropsychol Soc (2014) 0.75
Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging. Front Immunol (2016) 0.75
Immune aging and challenges for immune protection of the graying population. Aging Dis (2011) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 45.63
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry (2007) 7.23
Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA (2003) 6.17
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA (2008) 4.21
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Screening for dementia by memory testing. Neurology (1988) 3.93
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med (2004) 3.93
Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc (2003) 2.92
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc (2006) 2.35
Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15
Cued recall in amnesia. J Clin Neuropsychol (1984) 1.99
Genetic determinants of human health span and life span: progress and new opportunities. PLoS Genet (2007) 1.70
Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology (2009) 1.63
A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology (2006) 1.54
Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2008) 1.51
Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol (2006) 1.48
Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord (2010) 1.19
Neurological gait abnormalities and risk of falls in older adults. J Neurol (2009) 1.15
Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.15
Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics (2008) 1.06
CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis (2005) 1.04
Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population. Int J Geriatr Psychiatry (2004) 0.97
Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J Neurol (2005) 0.96
The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Neurogenetics (2007) 0.93
Cholesteryl ester transfer protein in human brain. Int J Clin Lab Res (1992) 0.91
Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions. J Neural Transm (Vienna) (2009) 0.88
Assessing genetic association with human survival at multi-allelic loci. Biogerontology (2004) 0.88
No association of CETP genotype with cognitive function or age-related cognitive change. Neurosci Lett (2007) 0.86
Egocentric and exocentric navigation skills in older adults. J Gerontol A Biol Sci Med Sci (2008) 0.84
Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues. Acta Neuropathol (1995) 0.81
Migraine--current understanding and treatment. N Engl J Med (2002) 9.80
Leisure activities and the risk of dementia in the elderly. N Engl J Med (2003) 8.77
Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A (2008) 5.14
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab (2002) 4.46
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med (2006) 3.90
Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med (2002) 3.88
Obesity and migraine: a population study. Neurology (2005) 3.67
Cognitive processes related to gait velocity: results from the Einstein Aging Study. Neuropsychology (2006) 3.34
The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem (2004) 3.31
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21
Validity of divided attention tasks in predicting falls in older individuals: a preliminary study. J Am Geriatr Soc (2002) 3.18
Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol (2006) 3.12
Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci (2009) 3.01
Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care (2009) 2.96
Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes (2002) 2.90
Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology (2008) 2.87
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache (2007) 2.75
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol (2010) 2.75
Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res (2005) 2.63
Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) (2004) 2.45
Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc (2006) 2.35
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) (2004) 2.32
The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain (2005) 2.25
The relationship between specific cognitive functions and falls in aging. Neuropsychology (2007) 2.17
Post-dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology. Headache (2010) 2.17
Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci (2012) 2.12
Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One (2010) 2.10
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09
Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab (2009) 2.04
Clinical phenotype of families with longevity. J Am Geriatr Soc (2004) 2.03
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord (2013) 2.01
Walking while talking: effect of task prioritization in the elderly. Arch Phys Med Rehabil (2007) 2.01
Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc (2008) 2.00
Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98
Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci U S A (2009) 1.96
Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache (2008) 1.95
Mechanisms of association between obesity and chronic pain in the elderly. Pain (2011) 1.94
Telephone screening for amnestic mild cognitive impairment. Neurology (2003) 1.93
Tissue-specific dysregulation of DNA methylation in aging. Aging Cell (2010) 1.90
Can patients with epilepsy predict their seizures? Neurology (2007) 1.90
Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research. Headache (2010) 1.88
Visceral adipose tissue modulates mammalian longevity. Aging Cell (2008) 1.87
Excessive acute migraine medication use and migraine progression. Neurology (2008) 1.83
Picture-based memory impairment screen for dementia. J Am Geriatr Soc (2012) 1.82
The epidemiology, burden, and comorbidities of migraine. Neurol Clin (2009) 1.81
Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab (2007) 1.80
Modeling memory decline in older adults: the importance of preclinical dementia, attrition, and chronological age. Psychol Aging (2003) 1.79
Motor stereotypies in children with autism and other developmental disorders. Dev Med Child Neurol (2009) 1.78
Psychiatric comorbidity of migraine. Headache (2006) 1.77
Reliability and validity of a telephone-based mobility assessment questionnaire. Age Ageing (2004) 1.77
Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology (2013) 1.75
Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology (2004) 1.75
Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci (2012) 1.72
Migraine and autonomic nervous system function: a population-based, case-control study. Neurology (2002) 1.71
Genetic determinants of human health span and life span: progress and new opportunities. PLoS Genet (2007) 1.70
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J (2005) 1.67
Effect of cognitive remediation on gait in sedentary seniors. J Gerontol A Biol Sci Med Sci (2010) 1.67
Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab (2009) 1.66
Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging. PLoS Comput Biol (2007) 1.64
Age-dependent prevalence and clinical features of migraine. Neurology (2006) 1.61
Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-Mennonites. Am J Med Genet A (2007) 1.61
Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology (2006) 1.60
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache (2009) 1.59
Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc (2002) 1.59
Humanin: a novel central regulator of peripheral insulin action. PLoS One (2009) 1.55
Excessive opioid use and the development of chronic migraine. Pain (2009) 1.55
Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology (2007) 1.55
Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm (2005) 1.54
Body mass index and episodic headaches: a population-based study. Arch Intern Med (2007) 1.54
Psychiatric comorbidities of episodic and chronic migraine. J Neurol (2012) 1.53
Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc (2008) 1.53
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache (2003) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache (2008) 1.51
Factors influencing long-term pessary use. Int Urogynecol J (2010) 1.51
Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache (2012) 1.51
Low socioeconomic status over 12 years and subclinical cardiovascular disease: the study of women's health across the nation. Stroke (2014) 1.50
Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes (2005) 1.50